Lower adherence among females and younger patients has previously also been documented for statin therapy.9 Contrary to oral LLDs, we did not observe differences in adherence or persistence to PCSK9 mAbs among patients with ASCVD compared to patients with FH. The gene discussed is PCSK9; the disease is atherosclerosis.